MedTrace Logo

Definity for Ultrasound of Intraocular Tumors

NCT01930968 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-02-23

No results posted yet for this study

Summary

The study will test the usefulness of a contrast agent to help image tumors in the eye. In this study, patients with eye melanoma who are going to have their eye removed, will have their eye imaged by ultrasound (sound waves) before and after intravenous injection of microbubbles. The pathology characteristics of the tumor in the removed eye will be compared with the images.

Conditions

  • Ocular Melanoma

Sponsors & Collaborators

  • Emory University

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01930968 on ClinicalTrials.gov